Brexidol 8 Medicated Plasters 14mg,Brexidol 8 Cerotti Medicati 14mg,PROMEDICA LTD

“ACTIVE ingredients: Piroxicam. Excipients: acrylic copolymer, Eudragit E 100; non-woven fabrics, polyester s iliconato.
INDICATIONS: Treatment of conditions of pain and inflammatory nature, rheumatic and between enlargement of joints, muscles, tendons and ligaments.
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance (piroxicam) or any of the other ingredients. In patients in whom substances with a similar mechanism of action (NSAIDs) have resulted in a hypersensitivity reaction. Patients with peptic ulcer disease in the active phase, in patients with bronchial asthma, a medical history of gastrointestinal bleeding from NSAIDs. Patients in ancient therapy ul. Pregnancy and lactation. Children under 12 years of age. The patch should not be used on open wounds or injuries, but only on the skin. Avoid contact with eyes and mucous membranes.
DOSAGE: It is recommended to use only the medicated patch once and replace it every 24 hours for a period not exceeding 8 days. Do not apply ec patches during the same day. Product for consumption exclusively on intact skin. After thoroughly rinsing the inflamed area, rub one of the corners between your fingers to remove the protective film and apply the sticky side directly to the skin. In case the patch is to be applied to joints, the greater the movement, such as the elbow or knee, and it is advisable to use a bandage to hold the applic lic joint in a bent position, in order to maintain the patch if de.
STORAGE: This medicine does not require any special conditions for storage.
WARNINGS: Serum levels achieved with beneficial results are essentially lower than those obtained by oral administration, but with strong individual variability, for which the occurrence of systemic side effects, especially at the gastrointestinal level, cannot be excluded. Painkillers, antipyretics, anti-inflammatory drugs or non-steroidal drugs, including piroxicam, can cause hypersensitivity reactions, potentially serious even in subjects not previously exposed to such drugs. These include attacks d’asthma, skin rashes, allergic rhinitis and anaphylactic reactions. Use with caution in patients with chronic obstructive bronchial diseases, allergic rhinitis or inflammation of the nasal mucosa (pol ipi nasal), in which asthmatic attacks are more frequent or localized inflammation of the skin and mucous membrane (Quincke’s edema). Use caution in patients with a medical history of peptic ulcer disease, in patients with a history of gastrointestinal bleeding not secondary to NSAID administration or with other bleeding disorders, in patients with Crohn’s disease or ulcerative colitis, with serious problems with epap, either kidneys or heart failure. Long-term use or repeated use of skin products may lead to skin sensitivity phenomena. In the presence of a hypersensitivity reaction, therapy should be avoided. Caution should be exercised when treating elderly patients, who tend to be more prone to adverse events. To avoid any phenomena of hypersensitivity or fotosensitivity, avoid exposure to direct sunlight.
INTERACTIONS: It is unlikely that the use of piroxicam-based patches with other medications. This does not, however, exclude the possibility of competition between piroxicam and other drugs that are absorbed and bind to plasma proteins. Do not use the product together with other oral or topical medications containing piroxicam or three FANS.
SIDE EFFECTS: use of the product may cause local skin reactions such as irritation or allergy, such as erythema, itching, burning, contact dermatitis or numbness and tingling at the site of application; with this medicine, cases of injuries, dermatological and extended, and serious, such as urticaria, angioedema, erythema multiforme, have been reported. I know there are no possible fotosensitivity reactions and skin reactions that are larger and more severe, including asthma attacks. Undesirable systemic reactions following the use of topical piroxicam are unlikely; because the plasma levels obtained are lower than those measured after systematic administration, but very different skills from person to person cannot exclude, especially in the case of long-term therapy for more than the period recommended, and not osse rvanza contraindications and warnings, the appearance The effects of indium sider are systemic, especially at the gastrointestinal level. The appearance of undesirable effects from general or at the site of application requires discontinuation of therapy.
PREGNANCY AND LACTATION: contraindicated during pregnancy and lactation, and these are not disadvantages that are recommended for wives”